Real-time enrollment status for this narcolepsy type 1 (nt1) clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 12:26 AM UTC
| NCT Number | NCT07584434 |
| Recruiting Status | Recruiting |
| Condition | Narcolepsy Type 1 (NT1) |
| Phase | PHASE1 |
| Target Enrollment | 118 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Vertex Pharmaceuticals Incorporated |
| Last Updated on CT.gov | June 8, 2026 (Jun 8, 2026) |
As of August 28, 2026: Clinical trial NCT07584434 is currently recruiting participants. This phase1 study for narcolepsy type 1 (nt1) is actively seeking new participants at 1 location across the United States. The study is sponsored by Vertex Pharmaceuticals Incorporated. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07584434 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07584434 was last updated Jun 8, 2026 (June 8, 2026). HelloStudys verifies this status automatically.